PowerFuge Pilot: A stainless-steel system for high-speed bioseparation
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 333249 Other Industrial Machinery Manufacturing
- Points of contact
-
- CDER Acquisition Liaison cderacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new requirement for the PowerFuge Pilot, a stainless-steel system designed for high-speed bioseparation utilizing robust liquid-solid separation methods through decanting centrifuge technology. This procurement targets pilot-scale microbial biomanufacturing applications, specifically for primary bioseparation of cells and culture fluid. The estimated solicitation release date is March 1, 2026, with an anticipated award date of May 1, 2026.
The estimated award value for this contract opportunity ranges from $250,000 to $700,000, with the procurement classified under NAICS code 333249 (Other Industrial Machinery Manufacturing). Interested vendors should direct inquiries to the FDA's Acquisition Liaison at cderacquisitions@fda.hhs.gov. No small business set-aside has been designated for this opportunity.
Forecast text
PowerFuge is a robust liquid-solid separation method (i.e, decanting centrifuge) and is used in pilot-scale microbial biomanufacturing for primary bioseparation of cells and culture fluid.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast